John Gillespie
AeroLeads people directory · profile

John Gillespie Email & Phone Number

President and CEO, AmberGen at AmberGen
Location: Greater Boston, United States 8 work roles 3 schools
2 work emails found @ambergen.com 2 phones found area 508 LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 100%

Contact Signals · 2 work emails · 2 phones

Work email j****@ambergen.com
Direct phone (508) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
President and CEO, AmberGen
Location
Greater Boston, United States

Who is John Gillespie? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

John Gillespie is listed as President and CEO, AmberGen at AmberGen, based in Greater Boston, United States. AeroLeads shows a work email signal at ambergen.com, phone signal with area code 508, and a matched LinkedIn profile for John Gillespie.

John Gillespie previously worked as President and CEO at Ambergen and Vice President, Product and Business Development at Ambergen. John Gillespie holds Bs, Biomedical Engineering from Boston University.

Company email context

Email format at AmberGen

This section adds company-level context without repeating John Gillespie's masked contact details.

{first}@ambergen.com
89% confidence

AeroLeads found 2 current-domain work email signals for John Gillespie. Compare company email patterns before reaching out.

Profile bio

About John Gillespie

I am the proud leader of AmberGen, whose new product Miralys(tm) MALDI HiPLEX-IHC was introduced in 2022. This breakthrough technology combines the techniques of Immunohistochemistry and Imaging Mass Spectrometry enabling the imaging of intact proteins in tissue samples. One key application is that it enables the imaging of small molecule drugs and their intended targets in the same tissue specimen, on the same instrument. It is remarkably high plex – allowing 100 or more protein biomarkers to be analyzed simultaneously without cycling of any kind. Since the tissue is not destroyed, it is multimodal-friendly allowing other spatial biology imaging modalities to be used either before or after. The technology's debut paper in JASMS (Yagnik et. al) has garnered tremendous interest, being one of the top 3 most downloaded JASMS articles for more than a year now. Interested in trying it? Contact us at AmberGen.com to learn more!

Listed skills include Medical Devices, Product Development, R&D, Fda, and 46 others.

Current workplace

John Gillespie's current company

Company context helps verify the profile and gives searchers a useful next step.

AmberGen
Ambergen
President and CEO, AmberGen
AeroLeads page
8 roles · 34 years

John Gillespie work experience

A career timeline built from the work history available for this profile.

President And Ceo

Current

Billerica, Ma, Us

It is truly an honor to be associated with the talented scientists of AmberGen whose mission is to transform clinical diagnostics and drug discovery. Founded in 1995 to commercialize pioneering photonic technology developed at Boston University’s Molecular Biophysics Laboratory and the Photonics Center, the company has continued to innovate by solving key problems that limit progress in medicine. AmberGen’s approach combines patented techniques in proteomics and light-based control of biomolecules

Apr 2022 - Present

Vice President, Product And Business Development

Billerica, Ma, Us

Jul 2015 - Apr 2022

Founder, Owner

Current

Dover, Us

Clover Medical's consultants can help ensure that your Medical Device company and its products are safe, compliant and launched into production as soon as possible.We are experts in areas including: - Medical Device Design Controls including Design History Files - Risk Management including Risk Mgmt. Files and FMEA - Design Input Requirements- Design Verification and Design Validation protocols, reports and testing- Package Validation Testing - Transferring your product to manufacturing- Working with contract manufacturers- Process Validation including IQ, OQ and PQ- 510(k) submissions and issues related to Class I and Class II products- Implementation and Validation of Pharma Serialization processes Our consultants have decades of experience at some of the world's largest medical device companies including Johnson and Johnson, Baxter Healthcare, Medtronic, and CR Bard (now Becton Dickinson). We take this experience and apply it to solving problems for emerging companies, like yours. Contact us at info@clovermedical.com

Nov 2010 - Present

Head Of Operations

Current

Clover Medical has been responsible for R&D, Manufacturing, Quality, and Regulatory Affairs for this startup company for more than a decade. Origami has developed a unique, patented portfolio engineered to enhance robotic-assisted surgery by allowing the surgeon to manage all aspects of suture use and needle disposal in clear view. Our technology is designed to improve safety, autonomy, and surgical efficiency.

Oct 2011 - Present

Vice President, R&D

Solace Therapeutics

R&D leader for this venture-capital funded startup company that is working to bring a groundbreaking new women's health related medical device to market.

Jul 2008 - Nov 2010

Group Director, R&D

New Brunswick, Nj, Us

Head of worldwide research and development, and member of the management board for three J&J businesses: Ethicon Products (the legendary worldwide leader in surgical wound closure); Ethicon Women's Health and Urology (formerly known as Gynecare, pioneeer and world leader in minimally-invasive surgical and therapeutic solutions for female pelvic health); and Cardiovations (innovator in minimally invasive heart surgery).

Oct 2004 - Jul 2008

General Manager, North America

Paris, Île-De-France, Fr

General Manager, North America, for the Telma subsidiary of Valeo Electrical Systems. Valeo is one of the world's leading automotive component suppliers.

2002 - 2004 ~2 yrs

Director, Product Development

Deerfield, Illinois, Us

Research and Development leader, and member of management board, for Baxter's Anesthesia business.

1993 - 2002 ~9 yrs
3 education records

John Gillespie education

Bs, Biomedical Engineering

Boston University

Ms, Electrical Engineerng

Boston University

Mba, General Management

Northwestern University - Kellogg School Of Management
FAQ

Frequently asked questions about John Gillespie

Quick answers generated from the profile data available on this page.

What company does John Gillespie work for?

John Gillespie works for AmberGen.

What is John Gillespie's role at AmberGen?

John Gillespie is listed as President and CEO, AmberGen at AmberGen.

What is John Gillespie's email address?

AeroLeads has found 2 work email signals at @ambergen.com for John Gillespie at AmberGen.

What is John Gillespie's phone number?

AeroLeads has found 2 phone signal(s) with area code 508 for John Gillespie at AmberGen.

Where is John Gillespie based?

John Gillespie is based in Greater Boston, United States while working with AmberGen.

What companies has John Gillespie worked for?

John Gillespie has worked for Ambergen, Clover Medical, Origami Surgical, Solace Therapeutics, and Johnson & Johnson Ethicon.

How can I contact John Gillespie?

You can use AeroLeads to view verified contact signals for John Gillespie at AmberGen, including work email, phone, and LinkedIn data when available.

What schools did John Gillespie attend?

John Gillespie holds Bs, Biomedical Engineering from Boston University.

What skills is John Gillespie known for?

John Gillespie is listed with skills including Medical Devices, Product Development, R&D, Fda, Quality System, Cross Functional Team Leadership, Design Control, and Iso 13485.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.